Cardiac safety of multidrug-resistant tuberculosis treatment: moving towards individualised monitoring

Lancet Infect Dis. 2021 Jul;21(7):894-895. doi: 10.1016/S1473-3099(20)30836-7. Epub 2021 Feb 12.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antitubercular Agents / adverse effects
  • Humans
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents